Cargando…
Lenvatinib vs. palliative therapy for stage IVC anaplastic thyroid cancer
Anaplastic thyroid cancer (ATC) is an orphan disease with extremely poor prognosis. In particular, unresectable stage IVC ATC is extremely difficult to treat and is associated with a survival of only a few months, even when treated with irradiation and/or chemotherapy. In 2015, lenvatinib was approv...
Autores principales: | Iwasaki, Hiroyuki, Toda, Soji, Suganuma, Nobuyasu, Murayama, Daisuke, Nakayama, Hirotaka, Masudo, Katsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951241/ https://www.ncbi.nlm.nih.gov/pubmed/31929884 http://dx.doi.org/10.3892/mco.2019.1964 |
Ejemplares similares
-
Invasive procedures in patients undergoing treatment with lenvatinib for thyroid cancer
por: Toda, Soji, et al.
Publicado: (2021) -
Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2019) -
Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report
por: Toda, Soji, et al.
Publicado: (2021) -
Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
por: Iwasaki, Hiroyuki, et al.
Publicado: (2023) -
A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis
por: Yamazaki, Haruhiko, et al.
Publicado: (2018)